Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho to Reshuffle CDFS's 1st, 2nd Committees on Drugs Next April
October 19, 2009
- Erbitux's Efficacy Correlated with KRAS Gene Mutation in Japanese Patients as Well
October 19, 2009
- Additional Safety Information to Be Provided on Obescare
October 19, 2009
- GSK, Novartis Contract with Korosho to Supply Flu Vaccines
October 19, 2009
- Terumo Applies for Left Ventricular Assist System
October 19, 2009
- Astellas to Apply for IBS in Women as Addn'l Indication for Irribow
October 19, 2009
- Some Healthcare Professionals Don't Recommend Use of Relief System to Their Patients to Save Time
October 19, 2009
- JPMA to Stress Value of New Drugs on TV
October 19, 2009
- BioJapan 2009
October 19, 2009
- Multaq Recommended for Approval in the EU: sanofi-aventis
October 19, 2009
- Takeda Introduces "Mutual Consent System" for Decision Making
October 19, 2009
- Mylan to Develop Cysteamine, Zeria Oral Phosphate
October 19, 2009
- Korosho to Support Development of 12 Unapproved Drugs
October 12, 2009
- MEDICAL DEVICE NEWS IN BRIEF
October 12, 2009
- R&D NEWS IN BRIEF
October 12, 2009
- NEW PRODUCTS
October 12, 2009
- Switch OTC Drugs Are Major Business Driver: SSP
October 12, 2009
- Ajinomoto Pharm. Aims at Sales of ¥100 Bil. in 5 Years
October 12, 2009
- Dr Hayakawa Calls For Flexible Applications of Guidance on Biosimilars
October 12, 2009
- Abbott to Acquire Solvay's Pharma Business
October 12, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…